Oncology
Cigarette Smoking-Related Carcinoma
2
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Cigarette Smoking-Related Carcinoma is an early-stage landscape with 2 programs across 1 company. The most active players are Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 21
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
2programs
Small molecule150%
Monoclonal antibody150%
Modality classified for 67% of 3 pipeline programs.
Analysis
Trial Status
5
clinical trials
Completed2 · 40%
Recruiting2 · 40%
Not yet recruiting1 · 20%
Clinical Trials
Trial Activity
Molecular Studies of Canakinumab in High-Risk Former-Smokers (CANIFS)
Completed·—·Phase 2·NCT06038526·41 enrolled
Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer in Rural Appalachia
Recruiting·OOhio State University Comprehensive Cancer Center·Preclinical·NCT06763536·1,000 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)